Background
Methods
Setting
Patients eligible for screening at health center level* | Mean (range) |
---|---|
Breast | 849 (86 to 3305) |
Cervical | 1,556 (131 to 5,195) |
Colorectal | 549 (82 to 3466) |
Number of months reporting any registry data* | 17 (12 to 18) |
Number of providers (physicians, nurse practitioners, physician assistants)** | 52 (7 to 205) |
Number of nurses (registered nurses, licensed practical nurses)** | 34 (1 to 103) |
Region of health centers*** | Number (proportion) |
Northeast | 3 (19%) |
Midwest | 4 (25%) |
South | 7 (44%) |
West | 2 (13%) |
Collaborative intervention
Performance measures
Practice registry data collection
Analyses
Number of health centers reporting | Percentage of health centers reporting | |
---|---|---|
Cancer Screening
| ||
Women with mammogram in last two years (age ≥42 years) | 16 | 100.0% |
Women with pap test within last three years (age ≥21) | 16 | 100.0% |
Adults appropriately screened for colorectal cancer (age ≥51) | 16 | 100.0% |
Breast cancer follow-up and treatment
| ||
Women notified of mammogram results within 30 days | 8 | 50.0% |
Women with follow-up evaluation of abnormal mammogram completed within 60 days | 2 | 12.5% |
Women with breast cancer starting treatment within 90 days | 1 | 6.25% |
Cervical cancer follow-up and treatment
| ||
Women notified of Pap test results within 30 days | 10 | 62.5% |
Women requiring colposcopy completing evaluation within 90 days | 3 | 18.75% |
Women with CIN 2,3 starting treatment within 90 days | 2 | 12.5% |
Colorectal cancer follow-up and treatment
| ||
Adults notified of colorectal cancer screening results within 30 days | 6 | 37.5% |
Adults with follow-up evaluation of positive FOBT within 8 weeks | 5 | 31.25% |
Adults with colon polyps or cancer starting treatment within 90 days | 2 | 12.5% |
Cancer care process | Eligible population | Process received | Eligible | Detectable change* |
---|---|---|---|---|
Cancer screening
| ||||
Mammography | Women age ≥42 | 2,373 | 10,522 | 2% |
Pap test | Women age ≥21 | 8,446 | 20,114 | 2% |
Colorectal cancer screening | Adults age ≥51 | 1,855 | 7,760 | 3% |
Breast cancer follow-up and treatment
| ||||
Documented notification of mammogram results within 30 days | Women receiving mammogram | 674 | 2,373 | 6% |
Additional evaluation within 60 days of abnormal mammogram | Women with abnormal mammogram | 30 | 125 | 24% |
Initial treatment within 90 days of diagnosis | Women diagnosed with breast cancer | 2 | 31 | 44% |
Cervical cancer follow-up and treatment
| ||||
Documented notification of Pap test results within 30 days | Women receiving Pap test | 2,325 | 8,446 | 3% |
Colposcopy evaluation within three months of abnormal Pap test | Women requiring colposcopy based on Pap test | 73 | 292 | 15% |
Initial treatment within 90 days of diagnosis | Women diagnosed with CIN2,3 | 8 | 34 | 47% |
Colorectal cancer follow-up and treatment
| ||||
Documented notification of colorectal cancer screening results within 30 days | Adults receiving colorectal screening | 575 | 1,855 | 6% |
Colonoscopy (or sigmoidoscopy and BE) within eight weeks of positive testing | Adults with abnormal FOBT | 29 | 123 | 24% |
Initial treatment within 90 days of diagnosis | Adults diagnosed with colon polyps or cancer | 1 | 33 | 40% |
Results
Practice registry data reporting patterns
Detectable change
Different approaches to presenting practice change
Individual versus aggregate level
Cancer screening | ||||
---|---|---|---|---|
Women with mammogram in last two years (age ≥42 years) | Women with pap test within last three years (age ≥21) | Adults appropriately screened for colorectal cancer (age ≥51) | ||
Aggregate collaborative
| Before numerator | 2,373 | 8,446 | 1,855 |
Before denominator | 10,522 | 20,114 | 7,760 | |
After numerator | 4,508 | 13,898 | 3,307 | |
After denominator | 13,003 | 24,300 | 11,968 | |
Before proportions | 23% | 42% | 24% | |
After proportions | 35% | 57% | 28% | |
Before/after chi-squared test | p < 0.001 | p < 0.001 | p < 0.001 | |
Individual health centers (out of 16 possible health centers) | Increase in before/after counts | 15/16 (94%) | 16/16 (100%) | 16/16 (100%) |
Increase in before/after proportions | 12/16 (75%) | 11/16 (69%) | 14/16 (88%) | |
Before/after chi-squared test significant | 7/16 (44%) | 6/16 (38%) | 5/16 (31%) |
Counts versus proportions
Mammography screening | Pap test screening | Colorectal cancer screening | |
---|---|---|---|
Screened/Eligible/Proportion | Screened/Eligible/Proportion | Screened/Eligible/Proportion | |
CHC 1 | 13/-1/15.6 | 16/-9/14.9 | 20/3/16.6 |
CHC 2 | 37/72/28.9 | 69/113/-9.8
| 31/66/30.7* |
CHC 3 | 105/226/-18.5
| 135/323/-25.6*
| 46/224/-11.8
|
CHC 4 | 513/347/24.2* | 807/996/3.9 | 298/214/19.3* |
CHC 5 | 78/258/6.2 | 746/817/57.0* | 58/158/20.4* |
CHC 6 | 110/160/27.7* | 427/444/37.5* | 28/135/3.9 |
CHC 7 | 60/-84/4.3* | 1133/710/23.9* | 290/58/16.7* |
CHC 8 | 205/252/14.1 | 296/341/12.0 | 140/153/7.9 |
CHC 9 | 351/730/-3.9
| 972/1379/-3.9
| 299/536/-7.7
|
CHC 10 | 69/114/10.0 | 125/153/23.0 | 34/109/2.8 |
CHC 11 | 400/-497/12.5* | 759/-2552/24.8* | 151/1747/2.6* |
CHC 12 | 215/328/8.7* | 220/453/5.2 | 86/416/0.1 |
CHC 13 | 6/51/-2.1
| 41/90/0.5 | 51/74/0.9 |
CHC 14 | 133/166/14.5* | 270/404/7.9 | 86/146/6.3 |
CHC 15 | 27/184/2.0 | 10/219/-1.5
| 29/146/3.3 |
CHC 16 | 1/251/-18.4* | 183/422/-4.7
| 6/-21/2.8 |